Vitiligo-like lesions in patients receiving anti-programmed cell death-1 therapies are distinct from spontaneously occurring active vitiligo

Affiliations

• ¹ Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France; INSERM U1035, BMGIC, Immunodermatology ATIP-AVENIR, University of Bordeaux, Bordeaux, France.
• ² Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France.
• ³ Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France; INSERM U1035, BMGIC, Immunodermatology ATIP-AVENIR, University of Bordeaux, Bordeaux, France. Electronic address: julien.seneschal@chu-bordeaux.fr.